This website uses cookies designed to give you the best experience when visiting our site. By continuing to use this website, you consent to our use of these cookies.
Find out more about how we use cookies and how to manage them by reading our Cookie Statement.
Close Cookie Notice

The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years. For many patients, these treatments offer fewer and less severe side effects, a shorter treatment duration, a less complex regimen and dramatically improved rates of success compared to current interferon-based treatments. With the arrival of these new treatments, what role will patients play in managing their condition? And what types of support will they need to achieve the best health results?

To address these unknowns, we spoke with people living with hepatitis C, interviewed experts and reviewed the latest adherence research in this therapeutic area. To find out what they had to say – see the latest report from the Adherence Research Summarized™ series.

The report includes:

  • Patient stories
  • Insights from experts
  • Predictors of non-adherence in hepatitis C
  • Proven interventions to improve adherence
  • Clinical literature review overview

Atlantis Healthcare specializes in the development and management of integrated, evidence-based patient support and adherence solutions.

For more information visit